Charlie's Holdings Fights Illicit Vapes, Eyes Uplist With New Tech

COSTA MESA, CA – April 29, 2026 – As the U.S. vapor market contends with a flood of unauthorized products and intense regulatory scrutiny, California-based Charlie's Holdings, Inc. is mounting a multi-front campaign to solidify its position and accelerate growth. The company (OTCQB: CHUC) this week announced its strategic participation in two major Las Vegas industry events in May, signaling a confident push involving legal engagement, product innovation, and a direct appeal to investors.

Company President Henry Sicignano and Chief Operating Officer Ryan Stump are spearheading an ambitious strategy that pits their premium vapor products against a challenging market landscape. Their plan involves not only showcasing existing lines but also tackling industry-wide issues head-on, from the proliferation of illicit devices to the complex debate over nicotine alternatives. This initiative comes as the company lays the groundwork for a potential uplist to a national stock exchange later this year, a move contingent on sustained growth and investor confidence.

The Two-Front War: Illicit Products and Regulatory Hurdles

In the company’s recent announcement, President Henry Sicignano pointedly noted the challenge of “illicit Chinese products…flooding the market this year.” This statement is not hyperbole but reflects a well-documented crisis facing the domestic industry. Federal agencies, including the FDA and the Department of Justice, have conducted numerous large-scale seizures of unauthorized e-cigarettes, with the vast majority originating from China. In one 2025 operation alone, officials seized over 4.7 million illicit units valued at more than $86 million.

Industry analyses and government reports suggest these illegal products, often featuring high nicotine concentrations and youth-appealing candy flavors, may constitute over 70% of the entire U.S. vape market. These products operate outside the FDA's stringent regulatory framework, which requires all new tobacco products to undergo a rigorous Premarket Tobacco Product Application (PMTA) review.

This backdrop makes Charlie's claim of “year-over-year improvement” particularly noteworthy. The company's financial filings support this assertion, showing a dramatic turnaround. For the fiscal year ending December 31, 2025, Charlie's reported revenue of $20.9 million, a 169% increase from the previous year, and swung from a $4.2 million net loss in 2024 to a $4.5 million net income in 2025. This performance, achieved amidst a market saturated with unregulated competition, is a cornerstone of the company’s forward-looking strategy.

A Bet on Technology: The 'Age-Gated' Solution

Perhaps the most ambitious element of Charlie’s plan is the upcoming launch of what it calls “America’s first age-gated flavored disposable vape.” This move is a direct attempt to thread the needle between consumer demand for flavors and the FDA’s primary concern: preventing youth access. The FDA has systematically denied marketing authorizations for nearly all flavored vaping products, citing their appeal to minors.

Age-gating technology represents a potential solution to this impasse. While the specifics of Charlie's system have not been disclosed, the concept generally involves integrating hardware and software locks into the device itself. These systems can require biometric authentication, like a thumbprint, or digital verification via a smartphone app to ensure the user is of legal age before the device will function. The goal is to create a product that is physically inoperable by anyone underage, going a step beyond retail-level ID checks required by federal Tobacco 21 laws and the PACT Act for online sales.

Charlie's is not alone in exploring this technological frontier. R.J. Reynolds has submitted a PMTA for its age-gated Vuse Pro platform, and tech firms like Ispire Technology and Atlas IoT are developing their own patented solutions. However, Charlie’s claim to be the “first” hinges on combining this technology with a flavored disposable product and, crucially, securing an elusive marketing order from the FDA. Success would represent a landmark achievement, potentially creating a new category of compliant, flavored products and setting a new standard for the industry.

Courting Wall Street: The Path to a National Exchange

Beyond product innovation, Charlie’s has its sights set on Wall Street. COO Ryan Stump has been candid about the company's goals, stating, “we are introducing Charlie’s to new investors at every opportunity” in preparation for an uplist to a major exchange like the NYSE or NASDAQ later in the year.

An uplist from the OTCQB market would provide significantly greater visibility, attract a broader base of institutional and retail investors, and increase shareholder liquidity—all goals Stump explicitly mentioned. To qualify, Charlie’s must meet stringent financial and corporate governance standards, including minimums for share price, market value, and shareholder equity. The company’s strong 2025 financial results and the recent removal of the “going concern” warning from its audit report are critical steps in building the case for such a move.

“Our goals are simple,” Stump explained in the press release, “to expand awareness of Charlie’s product portfolio; to increase the number of Charlie’s shareholders; to increase shareholder liquidity; and to increase long-term shareholder value.” This clear-eyed focus on financial maturation is designed to position the company not just as a product innovator, but as a robust and attractive investment.

Engaging the Industry in Las Vegas

The company’s strategic initiatives will converge in Las Vegas in May. First, President Henry Sicignano will take the stage as an expert panelist at the prestigious Keller & Heckman Tobacco Law Symposium. His participation in a discussion on “Nicotine Analogs: Legal, Public Health, and Scientific Considerations” places Charlie’s at the center of a critical industry debate over the regulation of synthetic nicotine and other novel products. This venue allows the company to demonstrate its thought leadership and engagement with the complex legal landscape.

Immediately following the symposium, Charlie’s will shift its focus to the CHAMPS Las Vegas Trade Show, a massive B2B exposition. At Booth #16503, the company will showcase its SBX and Pachamama product lines to a national audience of distributors and retailers. This dual-event strategy perfectly encapsulates the company's approach: engaging with regulators and legal experts on one hand, while driving sales and expanding its commercial footprint on the other.

As Sicignano commented, “we believe our success with SBX and Pachamama – in combination with our plans to launch America’s first age-gated flavored disposable vape – will make 2026 our best year ever.” By simultaneously tackling regulatory debates, pursuing technological solutions, and courting investors, Charlie’s is making a bold statement about its intent to not only survive in a turbulent market but to lead and define its future.